Centre immunologist recognised for major contributions to haematology research

World-leading immunologist Professor Freda Stevenson, from the Centre for Cancer Immunology, will be recognised by The American Society of Hematology (ASH) with the 2018 Henry M. Stratton Medal for her seminal contribution to haematology research.

Centre welcomes internationally renowned scientists

The Centre for Cancer Immunology is delighted to welcome Professors Sally Ward and Raimund Ober who will be heading up a joint multidisciplinary laboratory.

Southampton scientists discover how to see antibodies in solution

Scientists at the University of Southampton including those at the Centre for Cancer Immunology have developed a new method to understand how antibodies move in solution, which will help in their fight against cancer.

WE DID IT! We reached our £25m target

We are thrilled to announce we have reached our target of raising £25m for our new Centre for Cancer Immunology. Thanks to an overwhelming response from donors, fundraisers and supporters, across the UK and internationally, we have reached our campaign goal six months ahead of schedule.

#WearingWhite for World Cancer Day 1-4 Feb

This World Cancer Day, please join us in supporting our Centre for Cancer Immunology by wearing white and sharing your photos on social media using #WearingWhite 1-4 February 2018. You’ll be helping us spread the word about our life-saving research and our new world-leading Centre.

£24m raised for our new Centre

We are delighted to announce that we have now raised £24m for our new Centre – leaving just £1m to go to reach the final target by next summer! Thank you to all our supporters for helping us end this year on such a high.

Improved lymphoma survival

A University of Southampton study has found that combining two different immunotherapy treatments could dramatically improve lymphoma survival. 

Dr Sean Lim, who led the study, said: “By combining two specific antibodies we’ve increased the ability of the immune system to destroy cancer cells. It’s very exciting to see that this drug combination has an impact on survival.”

Helping people with blood cancer

An immunology discovery from the laboratories at the University of Southampton has now been shown to improve the outcomes of a common type of blood cancer in patients: follicular lymphoma, a type of non-Hodgkin lymphoma. Julie Davis, pictured here, took part in the trial at Southampton and is now in full remission.

A step closer to curing cancer

We are very excited to announce that our campaign is now entering its final fundraising phase thanks to a £2m gift! The generous donation, given by a Guernsey resident, means we are now in touching distance of our £25m target with the total now standing at £23.8m.

Blood Cancer Awareness Month – new lymphoma trial

September is National Blood Cancer Awareness Month. We have much to celebrate at the University of Southampton as our scientists are, for the first time, to trial a new experimental drug, in combination with immunochemotherapy, in certain patients with the most common type of fast-growing non-Hodgkin lymphoma, a type of blood cancer.